These changes adjust bile secretion and its metabolites (including chenodeoxycholic acid and glycocholic acid), activate the expression of TRG5 and GLP-1R, regulate blood glucose and lipid metabolic processes, enhance insulin production, and mitigate insulin resistance. This evidence concerns the gene INS and Insulin resistance.